Skip to main content

Month: May 2024

Freddie Mac Announces First Quarter 2024 Financial Results

MCLEAN, Va., May 01, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its First Quarter 2024 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company’s Form 10-Q and earnings press release, along with the First Quarter 2024 financial results supplement are available now on the Investor Relations page of the company’s website. The company will hold a call at 9 a.m. Eastern Time (ET) today, May 1, 2024, to share its results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, affordability and equity in the housing market throughout all economic cycles....

Continue reading

Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives

Acquire cell therapy manufacturing facility with clinical and commercial capabilities Further ExacTcell platform for additional clinical trials based on successful completion of POC Highlight full year financial results and clarify key financial itemsWARREN, N.J., May 01, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, announced financial results for full year 2023, business highlights, and upcoming operational objectives. “Saving lives remains our duty, and to that end, we remain committed to furthering our ExacTcell™ technology platform by moving Tevogen’s allogeneic cytotoxic CD8+ T lymphocytes (CTLs) into the...

Continue reading

Form 8.3 – Alpha Financial Markets Consulting plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Full name of discloser: OCTOPUS INVESTMENTS LTD(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Alpha Financial Markets Consulting plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date...

Continue reading

Arbe to Announce Q1 2024 Financial Results and Hold a Conference Call on May 22, 2024

Tel Aviv, Israel, May 1, 2024 — Arbe Robotics Ltd. (Nasdaq: ARBE) (“Arbe”), a global leader in Perception Radar Solutions, today announced that it will hold its first quarter conference call on Wednesday, March 22 at 8:30 a.m. Eastern Time. The company will issue its financial results before the market opens that same day. Conference Call and Webcast Details Speakers will include Kobi Marenko, Co-Founder and Chief Executive Officer and Karine Pinto-Flomenboim, Chief Financial Officer. The live call may be accessed via telephone at (844) 481-3015 toll-free, (80) 921-2373 Israel toll-free, or (412) 317-1880 internationally. A telephonic replay of the conference call will be available following the end of the conference call until June 5, 2024. To listen to the replay, please dial (877) 344-7529, or (412) 317-0088 internationally, using access...

Continue reading

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

DUBLIN, Ireland, May 01, 2024 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, May 8, 2024, to provide a corporate update and discuss the Company’s financial results for the first quarter ended March 31, 2024. To access the conference call, investors are invited to dial +1 (800) 715-9871 (U.S. and Canada) or +1 (646) 307-1963 (International) and use the conference ID 2270373. A live audio webcast of the call be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event. About Avadel Pharmaceuticals plcAvadel...

Continue reading

Primech Holdings Limited Engages Strategic Investor Relations to Enhance Investor Communications and Engagement

SINGAPORE, May 01, 2024 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company“), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, has engaged Strategic Investor Relations, a premier investor relations firm, to enhance Primech’s visibility in the financial community and support its ongoing efforts to engage and educate current and potential investors about the company’s growth and strategic initiatives. With this new partnership, Primech aims to refine its communication strategies and investor relations activities to ensure stakeholders are fully informed and engaged with the company’s progress and prospects. Strategic Investor Relations will assist Primech in highlighting its innovative solutions,...

Continue reading

Intouch Insight confirms: Investments into tech-superior restaurant prototypes are paying off

An Intouch Insight study has found that 7 out of 10 brands’ innovation experiences outperformed the legacy experiences. The investment made in these new restaurant prototypes, like Burger King’s Sizzle, Taco Bell’s Go Mobile, and Wendy’s Global NextGen, has resulted in notable improvements to key customer experience metrics. Ottawa, Ontario, May 01, 2024 (GLOBE NEWSWIRE) — Intouch Insight, a well-known provider of customer experience management solutions in North America, has released the second edition of its Emerging Experience study today in partnership with QSR® Magazine. The report, Next-Gen Restaurant Experiences: The Rise of Innovative Locations, is focused on how technology is impacting the customer experience for multi-location QSR brands. “We have been closely monitoring the latest trends in the...

Continue reading

VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting

Presentations will highlight positive preclinical and Phase 1b data of novel BET inhibitor, VYN201, in nonsegmental vitiligoBRIDGEWATER, N.J., May 01, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced two abstracts reporting results for its novel BET inhibitor, VYN201, have been selected for presentation at the 81st Annual Meeting of the Society for Investigative Dermatology (SID), being held May 15-18, 2024 in Dallas, TX, USA. “We look forward to sharing our preclinical and Phase 1b data for VYN201 with researchers and clinicians at the upcoming SID Annual Meeting,” said Iain Stuart, Ph.D., Chief Scientific Officer...

Continue reading

FOREWARN Partners with Greater Metropolitan Association of REALTORS®

The largest Association in the state of Michigan makes FOREWARN services available for its 7,500+ real estate professional members to promote proactive agent safety BOCA RATON, Fla., May 01, 2024 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Greater Metropolitan Association of REALTORS® (“GMAR”) will offer FOREWARN® services to its 7,500+ members it serves throughout Macomb, Oakland, and Wayne County in metro-Detroit to promote proactive real estate agent safety. Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided...

Continue reading

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

– CX-904 (masked EGFRxCD3 Probody® T-cell engager) preliminary Phase 1a results to be presented from ongoing dose escalation study – – Management to hold conference call at 5 p.m. EDT / 2 p.m. PDT on May 8th– SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that it will report first quarter 2024 results and provide an initial CX-904 Phase 1a dose escalation update on Wednesday, May 8, 2024, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT. Participants may access the live webcast of the conference call from the Events and Presentations page of CytomX’s website at https://ir.cytomx.com/events-and-presentations....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.